News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
248,770 Results
Type
Article (10881)
Company Profile (44)
Press Release (237845)
Section
Business (68835)
Career Advice (298)
Deals (13096)
Drug Delivery (45)
Drug Development (15112)
Employer Resources (51)
FDA (6973)
Job Trends (6455)
News (108569)
Policy (12437)
Tag
Academia (898)
Alliances (18801)
Alzheimer's disease (324)
Approvals (6976)
Artificial intelligence (87)
Bankruptcy (85)
Best Places to Work (5613)
Biosimilars (33)
Breast cancer (43)
Cancer (299)
Cardiovascular disease (39)
Career advice (282)
Cell therapy (51)
Clinical research (12417)
Collaboration (174)
COVID-19 (889)
C-suite (39)
Data (365)
Diabetes (57)
Diagnostics (3429)
Drug pricing (46)
Earnings (22400)
Employer resources (45)
Events (50615)
Executive appointments (137)
FDA (7247)
Funding (132)
Gene therapy (49)
GLP-1 (172)
Government (2309)
Healthcare (9679)
Infectious disease (925)
Inflammatory bowel disease (34)
IPO (5081)
Job creations (1047)
Job search strategy (263)
Layoffs (109)
Legal (2700)
Lung cancer (47)
Manufacturing (57)
Medical device (6768)
Medtech (6770)
Mergers & acquisitions (8106)
Metabolic disorders (162)
Neuroscience (391)
NextGen Class of 2024 (3465)
Non-profit (1778)
Northern California (517)
Obesity (101)
Opinion (83)
People (21835)
Phase I (2832)
Phase II (4461)
Phase III (5679)
Pipeline (155)
Policy (32)
Postmarket research (904)
Preclinical (952)
Radiopharmaceuticals (78)
Rare diseases (66)
Real estate (1791)
Regulatory (7992)
Research institute (763)
Southern California (402)
Startups (1473)
United States (5140)
Vaccines (152)
Weight loss (60)
Date
Last 7 days (211)
Last 30 days (1378)
Last 365 days (13500)
2024 (12640)
2023 (14729)
2022 (22673)
2021 (24461)
2020 (24423)
2019 (21898)
2018 (16371)
2017 (10886)
2016 (11628)
2015 (13592)
2014 (10043)
2013 (8352)
2012 (8890)
2011 (8995)
2010 (7280)
Location
Africa (306)
Arizona (60)
Asia (12638)
Australia (1835)
California (1114)
Canada (461)
China (92)
Colorado (73)
Connecticut (62)
Europe (31714)
Florida (191)
Georgia (61)
Illinois (162)
Indiana (93)
Japan (32)
Maryland (279)
Massachusetts (886)
Michigan (62)
Minnesota (89)
Missouri (35)
New Jersey (391)
New York (378)
North Carolina (327)
Northern California (517)
Ohio (44)
Pennsylvania (363)
South America (463)
Southern California (402)
Tennessee (33)
Texas (149)
Utah (53)
Washington State (114)
248,770 Results for "glaxosmithkline consumer healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Healthcare
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
Sanofi looks to follow a deep history of Big Pharma offloading their consumer healthcare businesses.
October 16, 2024
·
6 min read
·
Annalee Armstrong
Deals
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.
October 21, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
October 21, 2024
·
11 min read
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
·
5 min read
·
Annalee Armstrong
Press Releases
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
November 25, 2024
·
1 min read
Business
Pfizer Launches Direct-to-Consumer Portal for Migraine, Flu, COVID-19 Products
The company joins Eli Lilly in offering its own digital platform to more directly connect to patients, allowing them easier access to healthcare providers and prescription drugs.
August 28, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
First PFAS “Forever Chemicals” Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
Quest Diagnostics, the world’s leader in diagnostic information services, announced the availability of the first consumer-initiated, physician-ordered blood-draw test for PFAS chemicals with the option to confer over the phone with a physician about the results.
February 12, 2024
·
8 min read
Pharm Country
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon
Following GSK’s lead, Pfizer plans to lower its interest in Haleon from 32% to approximately 24%, with the sale of 630 million ordinary shares in the consumer healthcare spinoff.
March 18, 2024
·
1 min read
·
Tyler Patchen
Press Releases
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
November 18, 2024
·
5 min read
Owlet to Participate in the 8th Annual Cowen Future of the Consumer Conference
Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today its participation in the 8th Annual Cowen Future of the Consumer Conference, being held in New York City on June 4-5, 2024.
May 23, 2024
·
1 min read
1 of 24,877
Next
